Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

33.3%

1 terminated/withdrawn out of 3 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

67%

2 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
2(66.7%)
N/A
1(33.3%)
3Total
Phase 4(2)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT02080130Not ApplicableWithdrawn

Efficacy of Two Probiotic Preparations in Children With Acute Diarrhoea

Role: lead

NCT01883596Phase 4Unknown

Chlorhexidine Gluconate for Prevention of Ventilator Associated Pneumonia in Children.

Role: lead

NCT01631305Phase 4Completed

Levothyroxine for Children With Euthyroid Sick Syndrome

Role: lead

All 3 trials loaded